KUALA LUMPUR: Bintai Kinden Corp Bhd’s subsidiary, Bintai Healthcare Sdn Bhd has signed a deal to expand its healthcare product offering and market footprint in Malaysia.

       In a statement Tuesday, it said Bintai Healthcare had entered into a business collaboration agreement with NGT Solutions (M) Sdn Bhd (NGTS), an appointed healthcare organiser of Duopharma Biotech Bhd to jointly distribute Sinopharm’s Covid-19 vaccine to the private sector in Malaysia.

       Bintai Kinden executive director Azri Azerai said the collaboration between Bintai Healthcare and NGTS is an important milestone for Bintai group to enhance its capability as a healthcare provider to provide wider range of products and services including distribution of medical devices and healthcare solutions in Malaysia.

       “We already have the products to store, transport and distribute Covid-19 vaccines at various temperatures. Bintai Healthcare is the exclusive distributor for Greenie Medi Cold Chain Box produced by SLAB Asia Co Ltd, Korea (SLAB Asia) in Malaysia.

       “We aim to achieve a sales forecast of vaccination for 5,000 persons in the first three months once the vaccine is made available to the private sector,” he said.

       Under the agreement, NGTS as the healthcare organiser will be providing the manpower and clinical resources including personal protective equipment and medical equipment to assess, vaccinate and monitor individuals as well as managing emergency during the vaccination process.

       The agreement is not expected to have any material effect on the issued and paid up share capital of Bintai Kinden but is expected to contribute positively towards the future earnings of the Group.